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In the 21st century, a global antibacterial resistance crisis has risen and 
is threatening the lives of millions. In addition, it has been determined 
that antibiotic resistance has added tremendous financial and clinical 
burdens on the U.S. health care system, patients and their families. The 
rise of this crisis has in part been attributed to the lack of new drug 
developments in the field of antibiotics as well as the overuse and misuse 
of existing medications. A novel bacterial pathway must be discovered 
and exploited in the fight to combat the antibiotic resistance crisis.
DapE is an essential bacterial enzyme in the biosynthetic pathway 
responsible for the production of meso-diaminopimelic acid (m-DAP) and 
the amino acid lysine, which are critical to bacterial survival1. DapE is an 
ideal drug target because the human body does not employ the DapE
enzyme to manufacture lysine; humans must consume lysine in their 
diets. Thus, the elimination of mechanism-based toxicity, combined with 
the discovery of multiple potential inhibitors in our lab for this enzyme, 
makes DapE a great target to focus on toward the discovery of new 
antibiotics (Scheme 1). This research has proven to be fruitful, but little is 
known about DapE and its properties. Synthesis of disulfonates will 
advance our understanding of the DapE enzyme in exploring the impact 
of a conformational change triggered by substrate binding means for the 
catalytic mechanism of the DapE enzyme2. 
Scheme 1: DapE enzymatic reaction.
Figure 1: Two sulfates bound to the active site of DapE (PDB 5UEJ). 
The two zinc atoms in the active site are visible as silver spheres.
Methodology
The production of disulfonates is in accordance with a published 
procedure using dibromides as the starting material in a reaction to 
created disulfonates of varying chain lengths3.
Scheme 2: Synthesis of disulfonates of varying chain lengths.
Scheme 3: Synthesis of butane-1,4-disulfonate.
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➢ Butane-1,4-disulfonate was successfully synthesized (Scheme 3).
➢ Proton NMR demonstrated that the product mixture contains the 
desired molecule in it but contains some impurities (Table 1). 
➢ The synthesis of disulfonates using dibromides as starting material 
appears to be a viable synthetic avenue.
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➢ Purify product using either a titration with ether, a recrystallization from 
alcohol, or a barium chloride dihydrate solution washed and treated 
with sulfuric acid. 
➢ Test the product in the enzymatic assay developed in our lab4.
➢ Travel to Argonne National Laboratory in nearby Lemont to work with 
our collaborators to co-crystalize the molecules to determine their 
effects on the structure of DapE. 
➢ Run molecular docking simulations using Molecular Operating 
Environment (MOE) to determine the molecules’ exact effects on 
DapE when binding in the active site, in hopes of determining a 
possible mechanism for inhibition and for shifting the enzyme from the 
open conformation to the closed.
➢ Synthesize five, six, seven, and eight carbon-linked disulfonates using 
correlating dibromides.
➢ Initial Molecular Dynamics results suggest that the all-carbon linker 
sulfonates form poor interactions with intervening amino acid residues 
between the two charged binding sites. Therefore, we plan to 
synthesize PEG linked disulfonates. 
Component Proton Multiplicity Peak
Butane-1,4-
disulfonate
CH2 3 1.2 ppm
CH2 3 3.4 ppm
Table 1: 1H NMR Data (D2O)
Br      (CH2)n Br                           NaO3S      (CH2)n SO3Na 
Na2SO3
ethanol reflux
1. BaCl2
2. H2SO4
HO3S      (CH2)n         SO3H
n = 4,5,6,7,8
Scheme 4: Synthesis of disulfonate and purification
➢ If necessary, we may purify with barium salt as shown in Scheme 4.
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We observed the presence of two sulfate groups in the active site of DapE 
(Figure 1). The distance between the sulfates is 12.3 Å, which is farther 
than the distance between the negatively charged moieties of the 
substrate (~10 Å). We hypothesize that the two negative charges anchor 
the substrate, and that the shorter distance “pulls” the active site from the 
open into the closed form, enabling the catalytic mechanism to occur. The 
goal of this research is to mimic these two key negative charges with 
alkylene-linked disulfonates, varying the distance between them to 
discover whether the enzyme will be inhibited by these synthetic substrate 
mimetics, and whether DapE will be inhibited by the analogs.
Table 1: Comparison of carboxylates and sulfonates bound in open and 
closed forms of DapE, and targeted bis-sulfonates.
